Phenylketonuria

Phenylketonuria (PKU) is an autosomal recessive metabolic disorder characterized by the inability to metabolize the amino acid phenylalanine due to a deficiency in the enzyme phenylalanine hydroxylase (PAH). If untreated, toxic levels of phenylalanine accumulate in the blood and brain, leading to severe intellectual disability, seizures, and neurodevelopmental delays.

PKU is caused by mutations in the PAH gene located on chromosome 12q23.

1. This condition is inherited in an autosomal recessive pattern, requiring two defective alleles. There are no lifestyle causes; it is strictly a genetic metabolic error.

The deficiency of PAH prevents the conversion of phenylalanine to tyrosine. Phenylalanine levels rise, causing neurotoxicity through competitive inhibition of large neutral amino acid transport across the blood-brain barrier. Additionally, the resulting tyrosine deficiency impairs the synthesis of neurotransmitters (dopamine, norepinephrine) and melanin.

Global incidence varies, approximately 1:10,000 to 1:15,000 births. It is most prevalent in populations of European and Turkish descent and less common in African or Japanese populations. Both genders are affected equally.

• Consanguinity (parental marriage)
• Family history of PKU
• Carrier status of both parents

A. Early Symptoms

• Irritability


• Poor feeding


• Vomiting


• Musty body/urine odor B. Common Symptoms


• Intellectual disability


• Microcephaly


• Fair skin and hair (hypopigmentation)


• Behavioral issues C. Advanced Symptoms


• Epilepsy/Seizures


• Psychiatric disorders (anxiety/depression)


• Significant cognitive impairment


• Tremors or involuntary movements D. Emergency Symptoms


• Acute metabolic decompensation


• Status epilepticus

• Eczematous skin rashes
• Hypertonia and hyperreflexia
• Musty odor to sweat/urine
• Microcephaly

A. Clinical Assessment: Evaluation of developmental milestones.
B. Laboratory Testing: Newborn screening via tandem mass spectrometry.
C. Imaging Studies: MRI for white matter changes.
D. Functional Tests: Neuropsychological assessment.
E. Biopsy Findings: Generally not indicated.
F. Genetic Testing: PAH gene sequencing.
G. Differential Diagnosis: Biopterin-defect hyperphenylalaninemia, tyrosinemia.

Test Name: Plasma Phenylalanine Levels
Type: Blood Test
Purpose: Diagnosis and monitoring
Expected Findings: >1200 µmol/L in untreated PKU
Interpretation: Confirms diagnosis when elevated.

• Brain MRI: Assesses for dysmyelination or white matter hyperintensities in patients with poor metabolic control.

• Tetrahydrobiopterin (BH4) deficiency (distinguished by cofactor loading test)
• Transient hyperphenylalaninemia of the newborn

• Severe intellectual impairment
• ADHD-like symptoms
• Irreversible microcephaly
• Neurological degeneration if diet is abandoned.

A. Lifestyle Modifications: Strict low-phenylalanine diet.
B. Preventive Measures: Newborn screening (Guthrie test).
C. Medical Treatment:
| Drug Class | Examples | Mechanism |
| :--- | :--- | :--- |
| Cofactor Therapy | Sapropterin dihydrochloride | Increases PAH activity |
| Enzyme Substitution | Pegvaliase | Replaces deficient enzyme | D. Surgical Treatment: Not applicable.
E. Interventional Procedures: Specialized nutritional counseling.
F. Rehabilitation: Speech and occupational therapy.
G. Emergency Management: Hospitalization for metabolic stabilization.

Excellent if treated early (within 7–10 days of birth). Normal intellectual development is expected with lifelong adherence to dietary restrictions.

Newborn metabolic screening is the gold standard for secondary prevention. Genetic counseling is primary prevention for carriers.

The following homeopathic remedies have been historically indicated for symptoms associated with Phenylketonuria. Selection should be based on individualized symptom totality and constitutional assessment.

• Homeopathy by Hadhrat Mirza Tahir Ahmad (r.a.) — Primary clinical reference
• Robin Murphy — Lotus Materia Medica (3rd Edition)
• William Boericke — Pocket Manual of Homœopathic Materia Medica & Repertory
• ICD-10/ICD-11 Classification — World Health Organization
• Harrison's Principles of Internal Medicine (Reference Standard)

This clinical reference profile is compiled from authoritative medical sources for educational purposes. Always verify clinical data with current medical guidelines.

🔬 Lab Report Analyzer (Diagnostic Verification)

Upload your laboratory bloodwork PDF or paste your report text to automatically extract markers, detect units, and identify reference range variances related to Phenylketonuria.